Home care during the pancytopenic phase after allogeneic hematopoietic stem cell transplantation is advantageous compared with hospital care.
about
Specialist home-based nursing services for children with acute and chronic illnessesSpecialist home-based nursing services for children with acute and chronic illnessesTelephone follow-up, initiated by a hospital-based health professional, for postdischarge problems in patients discharged from hospital to homeGraft failure in the modern era of allogeneic hematopoietic SCT.Reduced plasma levels of soluble interleukin-7 receptor during graft-versus-host disease (GVHD) in children and adults.Isolation in the allogeneic transplant environment: how protective is it?Nutrition support challenges in hematopoietic stem cell transplant patients.Non-myeloablative allogeneic hematopoietic stem cell transplantation.Setting up low-risk bone marrow transplantation for children with thalassemia may facilitate pediatric cancer care.The allogeneic graft-versus-cancer effect.Symptoms after hospital discharge following hematopoietic stem cell transplantation.Safe early discharge for patients undergoing high dose chemotherapy with or without stem cell transplantation: a prospective analysis of clinical variables predictive for complications after treatment.Cause of death after allogeneic haematopoietic stem cell transplantation (HSCT) in early leukaemias: an EBMT analysis of lethal infectious complications and changes over calendar time.Patients' experiences of different care settings and a new life situation after allogeneic haematopoietic stem cell transplantation.Both high and low levels of cellular Epstein-Barr virus DNA in blood identify failure after hematologic stem cell transplantation in conjunction with acute GVHD and type of conditioning.Stem cell transplantation during cancer.Family members' life situation and experiences of different caring organisations during allogeneic haematopoietic stem cells transplantation-A qualitative study.Safety and Side Effects of Using Placenta-Derived Decidual Stromal Cells for Graft-versus-Host Disease and Hemorrhagic Cystitis.Allogeneic hematopoietic SCT performed in non-HEPA filter rooms: initial experience from a single center in India.Prolonged outbreak of adenovirus A31 in allogeneic stem cell transplant recipients.Early discharge after high dose chemotherapy is safe and feasible: a prospective evaluation of 6 years of home care.Quality of the hematopoietic stem cell graft affects the clinical outcome of allogeneic stem cell transplantation.Incidence, risk factors, and outcome of bloodstream infections during the pre-engraftment phase in 521 allogeneic hematopoietic stem cell transplantations.Environmental prevention of infection in stem cell transplant recipients: a survey of the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.Increased costs after allogeneic haematopoietic SCT are associated with major complications and re-transplantation.Home care during neutropenia after allogeneic hematopoietic stem cell transplantation in children and adolescents is safe and may be more advantageous than isolation in hospital.Performing allogeneic and autologous hematopoietic SCT in the outpatient setting: effects on infectious complications and early transplant outcomes.General health, symptom occurrence, and self-efficacy in adult survivors after allogeneic hematopoietic stem cell transplantation: a cross-sectional comparison between hospital care and home care.A prospective randomized toxicity study to compare reduced-intensity and myeloablative conditioning in patients with myeloid leukaemia undergoing allogeneic haematopoietic stem cell transplantation.Different impact of intermediate and unfavourable cytogenetics at the time of diagnosis on outcome of de novo AML after allo-SCT: a long-term retrospective analysis from a single institution.A prospective, randomised study on the use of well-fitting masks for prevention of invasive aspergillosis in high-risk patients.A prospective randomized study using N-acetyl-L-cysteine for early liver toxicity after allogeneic hematopoietic stem cell transplantation.Treatment with mesenchymal stromal cells is a risk factor for pneumonia-related death after allogeneic hematopoietic stem cell transplantation.Long-term outcome in patients treated at home during the pancytopenic phase after allogeneic haematopoietic stem cell transplantation.Health related quality of life and impact of infectious comorbidity in outpatient management of patients with acute leukemia.Hematopoietic SCT: a useful treatment for late metachromatic leukodystrophy.Characterization of long-term mixed donor-donor chimerism after double cord blood transplantation.Reduced intensity conditioning and oral care measures prevent oral mucositis and reduces days of hospitalization in allogeneic stem cell transplantation recipients.Risk factors for acute graft-versus-host disease grades II-IV after reduced intensity conditioning allogeneic stem cell transplantation with unrelated donors: a single centre study.Placenta-Derived Decidua Stromal Cells for Treatment of Severe Acute Graft-Versus-Host Disease.
P2860
Q24201949-52389592-3397-456F-8911-422C02A0664FQ24244012-B7391F4D-53B8-481C-AD98-F94C304090D3Q24244206-F3DA71D3-DC61-4C42-91A2-2A23307AA2FEQ33404733-3FC4047C-DB57-4CFD-9D4A-3C9460DE6BADQ33817588-78DC1F3B-C283-44A1-A597-9373D9DAD410Q36169360-E13924A3-B1A6-4690-B625-64B183BC466AQ37292173-29A1494B-891D-45E7-AA9E-0554C41948FCQ37308127-BF3D70BF-5C96-41B3-A03F-8210B2B6D93AQ37481685-EBF9AB29-327C-49B3-8B17-FD7562C761FBQ37593125-8D2D42D7-DF9C-410C-9917-1FD660C9C93CQ37596718-9547041F-8473-486C-91B5-1B5CAF462532Q38426941-86FB3645-1B0B-450E-9FB2-CF07187C2A54Q38472178-D58D8E9F-6104-40A3-9FBA-8575B4B43BCFQ38751585-F7D93A69-6FB5-4E18-A507-DC34097084F0Q38877813-BF23C989-D873-46D6-BB3F-8CE48BE876CFQ39095853-82718A78-5A99-4471-8177-5B23F911CA60Q39176991-E7701BC8-69C6-4300-8F2D-02B176BC362EQ40119705-2A76D10F-417C-4778-A7B7-DC54D9A8BA0EQ40409584-67A0F9BE-9245-4569-857B-DC8BEC465FF4Q41046376-F4320F7E-C9B2-40F7-A76B-946D0B7C0EB2Q41694812-C78A4226-09DF-4E6B-AFFC-96DD3C51CDB4Q41742166-26BD72C5-A40D-46A0-BB0A-DBD8A37C1598Q42234975-D794DC04-C209-47D3-AF90-711CEE6617AFQ42272250-03AA0584-DC26-43BC-A0E6-8938011B0050Q43430861-4DF3DAA0-C836-4FFD-A4A2-53F5A179BC48Q43486658-6CE6A22F-C090-44C3-95DE-B436E6CC74FDQ43610114-368C04A0-02F5-4B68-8973-E55513A200E8Q43988469-BB45B6B9-D50B-4E80-8BAD-61A71AF263D0Q44282612-13AD0C59-547A-4E71-BCF9-B90B622AF47AQ44331222-B81D2098-0D66-4C73-B409-2D1B4EF5CC97Q46006886-098C9F2F-F213-4876-AE09-376FB9775A5EQ46822195-869D188C-8A27-44C6-8E21-3A8AE872F8A6Q47416112-D6B2F486-87A4-43B8-A9C5-91F1B095A3EFQ48295098-434AA389-76E5-4898-912E-F7C1E545AAA8Q48467983-104F1C47-D869-4BDD-A833-4030BF45DD51Q48793441-74348387-4B06-4753-A8F0-7A1046D61C8BQ51040027-0B15EFF2-136F-48CC-9937-C5EDA2AF7D0FQ51152596-5196BE94-68E9-4410-ABB8-4730D27D7451Q51729292-2C998157-BA56-4007-92EA-A96D5555EB0BQ52658261-684F3A6D-51CD-4310-8DDA-E56359AE5B93
P2860
Home care during the pancytopenic phase after allogeneic hematopoietic stem cell transplantation is advantageous compared with hospital care.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Home care during the pancytope ...... s compared with hospital care.
@en
type
label
Home care during the pancytope ...... s compared with hospital care.
@en
prefLabel
Home care during the pancytope ...... s compared with hospital care.
@en
P2093
P1433
P1476
Home care during the pancytope ...... s compared with hospital care.
@en
P2093
Britt-Marie Svahn
Britta Eriksson
Johan Aschan
Karl-Erik Myrbäck
Katarina Holmberg
Lisbeth Barkholt
Mats Remberger
Olle Ringdén
Patrik Hentschke
P304
P356
10.1182/BLOOD-2002-03-0801
P407
P577
2002-08-22T00:00:00Z